Super-shoes
Evidence: strong
A genuine ~4% average economy gain, the rare case of running gear with a large, well-evidenced effect. But it varies a lot between runners, and the recovery/training-load claims are thin.
Super-shoes are racing shoes combining a thick slab of advanced foam with a stiff carbon plate. They are the rare case of running gear with a large, well-evidenced performance effect. The original study found a prototype Nike Vaporfly reduced the metabolic cost of running by about 4% versus contemporary racing flats, with shoe mass equalised so the effect came from design, not weight (Hoogkamer et al. 2018). The retail shoe was named the “4%” after that finding.
A tool, not a substitute
Super-shoes add a few per cent on top of the fitness you have already built. They do not replace training, and the gain is largest for runners who have the engine to use it. Put the basics first; the shoes are the last few per cent, not the first.
How big, and against what
The 4% figure is a group mean against 2017 flats, and it shrinks against other fast shoes: an independent test of the retail Vaporfly measured around 1.9 to 2.8% versus two comparison shoes (Barnes & Kipp 2019). A meta-analysis puts the pooled economy improvement near 2.9% (Kobayashi et al. 2025). The improvement comfortably exceeds the roughly 2.7% gain modelled as needed for a sub-two-hour marathon, which is why the technology reshaped the event (Hoogkamer, Kram & Arellano 2017).
The race record is consistent with the lab work. Every men’s marathon world record since 2018 was set in carbon-plated shoes, and statistical analyses of mass-participation races find wearers roughly 1.4 to 2.8% faster after controlling for ability (Guinness et al. 2020; Muniz-Pardos et al. 2021). The step-change in records coincides so tightly with the technology that simultaneous physiological gains are an implausible explanation.
Responders and non-responders
The average hides large individual variation. Combining studies, individual responses range from roughly an 11% hindrance to an 11% benefit, and world-class Kenyan runners showed no significant mean benefit with a wide spread (Knopp et al. 2023). No measured trait reliably predicts response; the one consistent biomechanical signal is shorter ground-contact time (Van Hooren 2025). The shoe that suits one runner often does not suit another, and a heavy super-shoe can net negative for a weak responder, since each extra 100 g per shoe raises the metabolic cost of running by about 1% (Hoogkamer et al. 2016).
The recovery and training-load claim is thin
The popular idea that super-shoes reduce muscle damage and so allow harder training or faster recovery is the weakest part of the evidence. There is no longitudinal training study and no direct measure of between-session recovery; every “train harder” claim is extrapolated from acute single-session data, and the most favourable results come from manufacturer-affiliated researchers (Kirby et al. 2019). The best controlled biomarker work found no difference in muscle damage between two super-shoe models, which says nothing either way about super-shoes versus conventional racing shoes, the comparison the recovery claim actually rests on (Alda-Blanco et al. 2025). The reduced-fatigue idea is plausible and physiologically reasonable, but it is currently a hypothesis, not a finding. Treat training-capacity benefits as unproven.
Durability, injury, rules
The foam’s advantage fades with mileage; see shoe foam durability. Injury implications are genuinely unresolved, with a navicular-stress-fracture alarm from case series set against a manufacturer-funded trial reporting fewer injuries; see carbon plate. World Athletics caps road-shoe stack height at 40 mm and permits a single rigid plate (World Athletics shoe regulations).